An exploratory study to optimize the administration of COMT inhibitor on LCIG therapy
Not Applicable
- Conditions
- Parkinson's disease
- Registration Number
- JPRN-UMIN000037390
- Lead Sponsor
- Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have difficulty showing consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma concentration of levodopa without COMT inhibitor, with COMT inhibitor at 13 o'clock, or at 15 o'clock
- Secondary Outcome Measures
Name Time Method